JLE

Néphrologie & Thérapeutique

MENU

Natural product therapies in chronic kidney diseases: An update Volume 18, issue 2, Avril 2022

Tables


  • Table 1
Authors

1 IntroductionChronic kidney disease (CKD) is a global public health problem with poor prognosis and limited intervention. 10% of the population worldwide is affected by CKD with high mortality [1]. In 2012, 1.5% of deaths worldwide were attributed to CKD [2]. The main medications for CKD are renin-angiotensin system (RAS) blockers, steroids, and immune suppressants. However, the positive effects of RAS blocker are limited [3]. Meanwhile, the side effects of steroids and immune suppressants are, [...]